ACN Newswire

日清食品（香港）慈善基金连续第四年支持 香港教育大学精英运动员

香港, 2026年1月31日 - (亚太商讯 via SeaPRwire.com) - 日清食品（香港）慈善基金（「慈善基金」）宣布连续第四年支持香港教育大学（「教大」）精英运动员，并举行2025/2026 学年日清食品精英运动员奖学金颁奖典礼，以表彰在各自运动领域中表现卓越、并立志成为未来教育工作者的七位精英运动员。该奖学金将支付整个修业期的全额学费，确保他们能够专注追求学业及运动目标，无须担心财务负担。该奖学金于2022年由日清食品（香港）慈善基金设立，以鼓励于教大修读健康教育（荣誉）学士课程、运动科学及教练（荣誉）理学士及学位教师教育文凭课程的精英运动员。此举措旨在支持他们的双轨事业发展，赋予他们能力成为合资格的健康教育工作者，同时在运动表现上继续追求卓越。2025/2026 学年的七名得奖者包括新晋及续期奖学金的精英运动员。四名新得奖的精英运动员分别是：铁人三项代表莫柏勋先生和黄柏尧先生、排球代表何健瑶小姐以及香港足毽队代表阎诺小姐。除了新的奖学金得主，慈善基金亦将该奖学金设为可续期形式，为精英运动员提供整个学习期间的资助支持。获得续期奖学金的三名精英运动员包括：前香港单车队代表蔡钧乐先生、赛艇代表陈柏匡先生及香港单车队代表刘睿哲先生。日清食品（香港）慈善基金主席安藤清隆先生表示：「日清食品在香港扎根逾 40 年，我们坚定不移地履行回馈社会的使命。奖学金直接体现了我们的创办人安藤百福先生『饮食和运动是健康的两大轴心』的理念。透过连续第四年支持教大的杰出运动员，我们不仅提供经济资助，更是在投资未来的领袖，他们将在我们的社会中倡导健康与福祉。我们很自豪能在他们的双轨发展道路上赋予他们力量，并深信他们将以杰出运动员和敬业教育工作者的双重身份，启发下一代。」香港教育大学副校长（研究与发展）陈智轩教授对长期的合作伙伴关系表达深切感谢。他表示：「教大致力推动精英运动员发展可持续的双轨事业路径。日清食品精英运动员奖学金的慷慨支持令我们能够让现役及退役运动员继续进修，同时认可了他们卓越的运动成就。我衷心祝贺所有奖学金得主，他们展现了极大的热情、决心和使命感，并诚挚感谢日清食品（香港）慈善基金及安藤先生对健康教育和精英运动员发展的巨大支持及信心。」主修中文及体育的学位教师教育深造文凭奖学金得奖人及杰出排球运动员何健瑶小姐对慈善基金表达衷心谢意。她说：「奖学金的支持赋予我们精英运动员学生力量，去追逐我们的抱负，并为社会带来有意义的影响。我们深信，我们能透过体育和教育的精神，创造更美好的未来。」图片说明日清食品（香港）慈善基金主席安藤清隆先生（中间右）及香港教育大学副校长（研究与发展）陈智轩教授（中间左）于2026年1月27日出席2025/2026学年日清食品精英运动员奖学金颁奖典礼。五名奖学金得主参与典礼，包括四名新得奖的精英运动员学生（从左至右）莫柏勋先生、黄柏尧先生、何健瑶小姐及阎诺小姐，以及获得续期奖学金的精英运动员学生蔡钧乐先生。 2025/2026年度日清食品精英运动员奖学金得奖人在各自领域均表现出色。左上起：铁人三项代表黄柏尧先生、排球代表何健瑶小姐、铁人三项代表莫柏勋先生、香港足毽队代表阎诺小姐、前香港单车队代表蔡钧乐先生、赛艇代表陈柏匡先生及香港单车队代表刘睿哲先生。关于日清食品（香港）慈善基金日清食品（香港）慈善基金（「慈善基金」）于2020年 9月由日清食品有限公司（股份编号： 1475）以信托契约的形式成立。慈善基金致力推动教育、教学、学习、艺术、科学和学术研究、援助有需要人士及进行惠及香港社区的慈善工作。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Business

45年前，一部科幻经典迎来姗姗来迟的精彩续作

Universal Pictures(SeaPRwire) -   1957年的电影《不可思议的收缩人》被誉为那个时代具有定义性的科幻片之一。这部视觉上令人印象深刻的奇幻之作，其惊奇感——以及极度的恐惧——并非来自深空或遥远的未来，而是源于日常生活的平淡无奇。而导演、编剧简·瓦格纳以及才华横溢的喜剧演员莉莉·汤姆林则认为，它是拍摄一部……的绝佳候选。45年前的今天上映的1981年电影《……》，最初被构思为杰克·阿诺德原版电影（其本身改编自理查德·马特森的小说《收缩人》）的直接续集，故事将聚焦妻子路易丝进入她失踪丈夫的微观世界。但这个想法一直陷于开发困境，直到1970年代末，约翰·兰迪斯认为它需要进行喜剧化改造。不幸的是，由于预算限制（兰迪斯曾设想打造一场他称之为“《……》与《我爱露西》的混合体”的奇观）和其他工作安排（一部名为《……》的鲜为人知的电影），最终将这部影片搬上银幕的任务落在了舒马赫身上。这位首次执导的导演，当时以联合编剧音乐电影《新绿野仙踪》、《洗车场》和《火花》而闻名，后来承认自己力不从心，但多亏了他的女主角无可估量的才华相助。的确，即使缩小到火柴棍大小，汤姆林依然能点亮整个银幕。她也有大量机会展示自己的才华，重现了她单人舞台剧中的角色（不苟言笑的有机化妆品销售员朱迪丝）和《罗恩和马丁的搞笑剧场》中的角色（粗鲁的电话接线员欧内斯廷），以及郊区家庭主妇帕特的正常尺寸和迷你版本。埃迪·墨菲，你就羡慕吧。莉莉·汤姆林饰演的不可思议的收缩女人登上脱口秀节目。 | Universal Pictures当然，占据中心舞台的是帕特，这位女性因对丈夫万斯（查尔斯·格罗丁饰）——一位广告公司高管——带回家的实验性家用产品产生不良反应，随后成为媒体轰动人物，并成为一家作恶公司的首要目标。汤姆林精准地演绎了这种视角剧变带来的困惑和焦虑，有时表现得像一种令人不安的身体恐怖。但有了美国最有趣的女性之一坐镇，《不可思议的收缩女人》更感兴趣的是从其奇幻情境中挖掘喜剧效果。帕特变得如此之小，被迫住在娃娃屋里，用贝琪尿尿娃娃来淋浴。接着是闹剧般的桥段，我们这位小不点女主角穿着小波普的服装，意外地从婚床上被甩到滑板上，然后落入一个肯娃娃的怀抱。再加上她掉进垃圾处理器后被腐烂食物覆盖的恶心场景，很明显汤姆林为她的艺术吃了苦头。克雷默夫妇在他们独特的、色彩柔和的住所里。 | Universal Pictures瓦格纳，汤姆林现实生活中的伴侣，也从不放过从这种离奇情境中挖掘双关语的机会。“等你从肥皂箱上下来我们再谈，”万斯在一次争吵后宣称，而他的妻子，是的，你猜对了，正字面意义上地站在一个肥皂箱上。还有那场葬礼，在帕特被推定于垃圾处理器事故中丧生后举行，朱迪丝致悼词时说：“没人能填补她的鞋子。” 咚-咚-锵。除了有趣的双关语和滑稽的特技外，《不可思议的收缩女人》还加入了一些讽刺作为调剂。那些爱看热闹的媒体因为幸灾乐祸地扑向他人的不幸而受到抨击；预示着一个凡事都被分析到极致的电视环境，一位新闻主播大声质疑帕特的磨难是否是一种隐喻（“家庭主妇的角色变得越来越无足轻重……”）。它还猛烈抨击了消费文化，从广告业的虚假承诺到对我们摄入体内之物乐呵呵的无知。朱迪丝在麦片货架旁仔细查看成分（“公牛阴囊的肿胀组织”）的过程，很可能让你这辈子都对Cheerios敬而远之。影片在超市外开始和结束并非巧合。当食物比你人还大时，吃饭可就难了。 | Universal Pictures恰如其分的是，《不可思议的收缩女人》在聚焦于“小”事物时远比深入其宏大阴谋更为有效，后者感觉更适合舒马赫后来的类型大片，而非这部原本亲切的家庭喜剧。影片的概念本身已经足够大胆，无需再添加一个聪明的大猩猩、一个狂热的科学怪人和一家决心用帕特的血液来缩小全人类的 shady corporation。至少，与原版不同，它让观众带着微笑而非存在主义的绝望回家。当格兰特·威廉姆斯饰演的不可思议的收缩人在极其黯淡的结局中接受了他渺小的命运和永恒的孤独时，汤姆林则恢复了正常状态，引发她病症的同一种未知化学物质也被证明是解药。好吧，至少是暂时的。在一个暗示续集的最后一刻转折中，帕特意识到她现在长得有点太大了。尽管明星尽了最大努力，《不可思议的收缩女人》并未取得显著成功，其可观但不足以支撑续集的票房成绩也终结了任何进一步的变形冒险。尽管如此，凭借其迷人的实体特效、鲜艳的柔和色彩美学，以及一位处于巅峰状态的喜剧女演员赢得人心的领衔表演，这部小体量的冒险片依然充满了巨大的乐趣。《不可思议的收缩女人》正在 Amazon Prime 上播放。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

Latest News

委内瑞拉代总统在特朗普政府压力下改革石油行业

(SeaPRwire) -   委内瑞拉代总统德尔西·罗德里格斯（Delcy Rodriguez）签署了一项改革该国石油行业的法律，将其向私有化开放。此举逆转了统治该国逾20年的社会主义运动的一项核心政策。 罗德里格斯的政策转变旨在吸引行业重组所需的外国投资者，而这一转变发生在美国抓获委内瑞拉前独裁领导人 后不到一个月。这位代总统在马杜罗（Maduro）被捕前曾担任其副总统，当时正面临特朗普政府的压力——特朗普政府在实施制裁后一直觊觎委内瑞拉的石油行业。 1月10日，特朗普在 接待了近24位顶级石油和天然气高管。他表示，美国能源公司将投资1000亿美元重建委内瑞拉“腐朽”的石油基础设施，并将产量推至创纪录水平。 同日，特朗普签署了一项题为《为美国和委内瑞拉人民的利益保护委内瑞拉石油收入》的行政命令，禁止美国法院扣押委内瑞拉存放在美国财政部账户中的石油收入。 据美联社（The Associated Press）报道，罗德里格斯在谈到这项改革时表示：“我们谈论的是未来，我们谈论的是我们将要留给子孙后代的国家。” 据美联社（AP）报道，该立法结束了国有委内瑞拉国家石油公司（Petróleos de Venezuela SA，简称PDVSA）对石油生产、销售及定价的垄断，并允许私营企业接管控制权。 据美联社报道，新法律规定，私营企业“在通过委内瑞拉石油部批准的商业计划证明其财务和技术能力后，将自费、自担风险并自行负责地全面管理相关活动”。不过，该媒体补充称，法律仍将私营企业运营的油气储量控制权保留在政府手中。 据美联社报道，该法律还允许对争端进行独立仲裁，取消了必须在执政党控制的委内瑞拉法院解决争端的要求。此外，它修改了开采税，将特许权使用费上限设定为30%。 据美联社报道， 总统与国务卿马可·卢比奥（Marco Rubio）周四与罗德里格斯进行了交谈。美联社补充称，就在一天前，国务卿向参议员们解释了政府计划如何处理委内瑞拉数千万桶石油的销售问题。该媒体指出，委内瑞拉拥有世界上最大的原油储量。 卢比奥在周三的参议院听证会上表示：“我们希望实现的是向一种机制过渡，让石油能够以正常方式销售，形成一个正常的石油行业——不是由亲信主导，也不是由贪污腐败主导的行业。” 国务卿表示，美国将保留对石油收入的控制权，委内瑞拉需提交月度预算，列出需要资助的项目。随后，资金将转入一个由美国监督的账户。他解释称，这笔钱不会由美国持有，但华盛顿将控制其支出，以确保其惠及委内瑞拉人民。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

Latest News

乌克兰加紧加强防空力量 以应对普京袭击暂停期临近结束

(SeaPRwire) -   随着俄罗斯对基辅和其他城市短暂的袭击暂停即将结束，乌克兰正加紧加强其防空能力，而军事和外交专家警告称，此举可能对战场形势改变甚微，并最终可能加强莫斯科的谈判地位。周五早些时候，总统在白宫表示，“我认为我们离达成一项协议非常近了，”他对即将到来的俄乌会谈表示乐观。“泽连斯基和普京互相憎恨，这使得事情非常困难，但我认为我们很有可能达成协议。”克里姆林宫表示，弗拉基米尔·普京总统同意特朗普的个人请求，暂停对基辅的空袭直至2月1日，以创造其所谓的有利于谈判的条件。乌克兰官员强调，没有正式的停火协议。随着基辅气温预计从周日开始将骤降至零下26摄氏度，总统弗拉基米尔·泽连斯基表示，乌克兰正在加强对南部和东北部前线城市的无人机短程防空能力。泽连斯基在Telegram上表示，“必须加强我们城市，如赫尔松和尼科波尔，以及苏梅地区边境社区的防空能力，以抵御俄罗斯无人机，因为俄罗斯在那里实际上已经对平民展开了持续的‘狩猎’。”尽管有暂停，俄罗斯议员和地方领导人却公开呼吁升级冲突。俄罗斯议长维亚切斯拉夫·沃洛金表示，议员们呼吁使用更强大的“报复性武器”，而车臣领导人拉姆赞·卡德罗夫则表示他反对任何谈判。在此背景下，专家告诉 Digital，此次暂停似乎更多是象征性的，而非具有变革性。退役海军上将、美国中央司令部副司令罗伯特·S·哈沃德表示，此次暂停袭击反映了的意愿，而非军事上的转变。哈沃德告诉 Digital，“这在对话和我们谈判的阶段具有象征意义。”“希望向美国表明，他与普京的关系能带来成果。这是对他关系的验证，可能预示着结束战争的整体谈判走向。”Vandenberg Coalition执行董事、前美国国务院和美国驻联合国代表卡莉·菲利皮表示，不应将的举动误读为和平的信号。菲利皮表示，“虽然我确信乌克兰平民会欢迎任何短暂的暂停，但他们也不会抱有幻想，因为普京的战争机器不会停止，直到他改变继续战争的风险计算。”她补充说，暂停时间很短，这让乌克兰处于危险之中。她表示，“鉴于暂停时间很短，以及俄罗斯声称同意为期一周的暂停但两天后就到期，这并没有实质性地改变战场上的任何条件。”哈沃德表示，暂停结束后，乌克兰可能面临外交后果。他表示，“乌克兰的风险在于，这会进一步削弱和孤立其在谈判中的地位。”泽连斯基还警告说，由于的延误，乌克兰保护平民的能力受到了影响。他说，欧洲盟友推迟了PURL武器采购计划下的付款，导致乌克兰在最近俄罗斯的袭击中，在基辅部分地区停电前没有爱国者防空导弹。菲利皮表示，“这对保护平民、乌克兰城市和乌克兰能源基础设施度过严寒的冬季至关重要。”“正如泽连斯基总统所说，如果他们没有足够的爱国者导弹来抵御俄罗斯的弹道导弹，那么平民将没有电力，也就没有暖气。”哈沃德指出，这个问题不仅限于乌克兰。他表示，“考虑到，全球对防空系统的需求一直很高。”“资源、开支以及交付和实施能力所需的时间增加，都加剧了挑战。”关于此次暂停是否会为更广泛的降级打开大门，两位专家都表示谨慎。哈沃德表示，“这种战术暂停只会进一步加强俄罗斯的谈判地位。”“普京正在向世界表明，他愿意倾听和回应。作为回报，他将要求更多地支持他的立场和要求。”菲利皮表示，“只有时间会告诉我们答案。”“外交可能一直显得徒劳无功，直到达成真正的协议。如果这次短暂的暂停，通过特朗普总统持续的接触和对普京的施压而实现，能够用于建立额外的，那将是一个非常积极的结果。”路透社对此报道有贡献。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

Business

六年后，星际迷航刚刚抛出一个重大转折

Paramount+(SeaPRwire) -   2020年，当《星际迷航：发现号》（Star Trek: Discovery）播出时，粉丝们有一个疑问：克林贡人发生了什么事？虽然23世纪的克林贡人在应对[原文缺失内容]，但遥远未来的克林贡人却不见踪影。不过现在，《星际舰队学院》（Starfleet Academy）推出了一集精彩的剧集，彻底解答了关于克林贡人的疑问。本季第四集《Vox in Excelso》以一个古怪的前提开场，但最终展现出纯粹的老派《星际迷航》风格。卡里姆·黛安（Karim Diane）饰演的常驻和平主义克林贡人杰伊-丹（Jay-Den）是本集的焦点，他与剧集运作人一起帮助《Inverse》解读了这一集的核心内容，以及他们如何在不失去克林贡人独特核心的前提下展现其新的一面。前方剧透。闪回中的杰伊-丹一家 | Brooke Palmer/Paramount+.《Vox in Excelso》在拉丁语中意为“来自高处的声音”，这一集以对声音和对话的字面探讨开场。事实证明，星际舰队学院有一个演讲辩论队，博士（罗伯特·皮卡多 Robert Picardo 饰）是他们的教练。我们了解到迦勒（桑德罗·罗斯塔 Sandro Rosta 饰）非常擅长辩论，而杰伊-丹则害怕公开演讲。但这一集只是以此为切入点，因为我们很快发现，克林贡人不再是庞大帝国的统治者，而是散布在整个银河系的难民，如今只剩下八个主要的克林贡家族。本质上，这就是《发现号》疑问的答案。克林贡人之所以在《发现号》时代缺席，是因为在“大燃烧”（the Burn）之后，帝国崩溃了，而克林贡人拒绝了帮助。“我认为我们必须提出这样的问题：为什么我们在这个时代从未见过克林贡人？在32世纪做一个克林贡人意味着什么？”兰道（Landau）在接受《Inverse》采访时表示。“这引发了一场非常重要的对话：如今地球上有多少难民，如果克林贡帝国变成一个没有家园、无处可去、失去帝国的散居族群，那意味着什么？但他们从未失去作为克林贡人的身份。”娜赫拉（Nahla）尽力理解克林贡人，但即使她拥有数百年的智慧，也无法匹敌杰伊-丹的尖锐观点。 | Paramount+当悲剧发生，仅剩的几艘克林贡难民船中的几艘被摧毁时，寻找新家园的需求变得迫切，星际舰队想要提供帮助。就在这时，这一集的核心辩论变得有趣起来：杰伊-丹知道，让克林贡人接受帮助的唯一方法是在不破坏他们文化的前提下进行。这是《星际迷航》中许多关于多元文化主义的精彩对话的核心论点；正如克林贡总理阿泽特布尔（Azetbur，罗珊娜·德索托 Rosanna DeSoto 饰）在1991年的[原文缺失作品名]中所说：“联邦不过是一个只针对智人的俱乐部。”本质上，《Vox in Excelso》在几个世纪后重新拾起了这场对话。联邦显然重视多元主义，但即使是像杰伊-丹这样非典型的和平主义克林贡人也知道，不能以拯救的名义夺走别人的文化。克林贡人的问题需要克林贡人的解决方案。“杰伊-丹在这一集中的旅程就是寻找自己的声音，”卡里姆·黛安说。“这也是我正在经历的旅程，字面意义上的寻找他的声音。我能给这个声音注入多少情感？我认为你们会继续看到他和我在声音上以及情感上发展我们的声音。”像害羞的杰伊-丹一样，沃尔夫（Worf）的儿子亚历山大（Alexander）不想成为一名战士。 | Paramount+当黛安谈论他的克林贡分身时，他会在自己柔和的自然声音和杰伊-丹低沉的男中音之间切换。这也体现了多元主义。黛安塑造了杰伊-丹，但他给这个害羞的克林贡人注入了一些意想不到的参考点。黛安在拿到这个角色时做了功课，这意味着他要了解克林贡人的各个方面，而不仅仅是大家都知道的刻板印象。“我想说，也许那些我观看和研究亚历山大的剧集对我有影响，”黛安透露，他指的是《下一代》（The Next Generation）和《深空九号》（Deep Space Nine）中沃尔夫的儿子。“通过那些剧集，我意识到克林贡人并不都是一个样子。他们有多种存在方式。”这并不是说杰伊-丹和亚历山大完全一样，但随着黛安延续这个骄傲而复杂的外星种族的传统，他再次证明了克林贡人是多元的。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。星际舰队学院（Starfleet Academy）在 Paramount+ 上线播出。

Latest News

随着特朗普政府加大对联合国的施压，联合国面临严重现金危机

(SeaPRwire) -   由于特朗普政府削减资金并退出多个国际组织，理由是批评联合国未能促进美国利益，联合国警告称，到7月可能面临现金危机。在1月28日联合国秘书长安东尼奥·古特雷斯致各国大使的信中，他提到了创纪录的未缴会费以及僵化的预算规则，这些使得该组织面临风险。古特雷斯表示，联合国陷入了一个“卡夫卡式的循环”，即僵化的预算规则迫使它退还“未使用”的资金，即使这些捐款从未支付过。他说，截至2025年底，未缴会费达到创纪录的15.68亿美元，收款仅占摊款的76.7%，使该组织面临巨大风险。古特雷斯警告称，除非收款情况“大幅改善”，否则联合国将无法全面实施其2026年预算，并可能在年中面临流动性危机。一位高级外交消息人士告诉《数字》杂志，秘书长本人对危机的加深负有重大责任，称早在当前资金短缺之前，警示信号就已显现。据该消息人士称，主要捐助国多年来一直敦促提高效率和进行改革，但有意义的行动却被推迟。消息人士称，当改革最终推出时，它们是全面实施的，而不是通过在可能实现真正节省的领域进行有针对性的削减，甚至损害了被认为对本组织使命至关重要的联合国机构。“他将成为联合国历史上最糟糕的秘书长，”该消息人士说。古特雷斯发出警告之际，作为联合国最大捐助国的美国，削减了对多个联合国项目的自愿资金，并拒绝支付一些所需款项，加深了秘书长信中所述的资金紧张局面。在特朗普政府外交政策调整下，美国大幅削减了对外援助。2026年1月，美国正式退出并开始退出数十个国际组织，包括多个联合国实体，理由是与美国优先事项不符。资金紧张已经迫使联合国在多个机构收紧开支。路透社的单独报道显示，随着总体捐款降至十年来的最低水平，包括世界粮食计划署和难民机构在内的联合国机构正在准备裁员和削减项目。前总统国家安全委员会特别助理、国际组织事务高级主任休·杜根告诉《数字》杂志，当前的动荡反映了长期存在的结构性弱点，而不是突然崩溃。“我们以前听过这种说法，”杜根在接受《数字》杂志采访时表示，他指的是联合国领导层多次就资金短缺发出的警告。杜根表示，该组织几十年来一直受收入不稳定和过时财务做法的困扰，他认为，在没有明显内部改革的情况下，危言耸听的信息不太可能恢复捐助者的信心。他说，任期还剩大约11个月的古特雷斯似乎专注于确保该机构在他任期内不会关闭。“大门将继续敞开，也许只是勉强敞开，但这就是他的遗产，”杜根说。当被问及某个事物时，杜根表示，它不应被视为联合国的竞争对手或其基于宪章的体系的替代品。“我不认为它是对联合国原则的替代，”他说，并将该倡议描述为务实而非意识形态的。杜根将其与过去的召集努力，如克林顿全球倡议进行了比较，称它侧重于交易和协调，而不是取代国际秩序。尽管对其表现和财务状况的批评不断增加，但杜根表示，联合国仍然拥有一个持久的优势。谈到联合国大会年度辩论时，杜根说：“如今，当联合国召开会议时，通常会有100多位国家元首出席，”他说，“召集的权力可不是一件小事。”本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

JCN Newswire

NTT DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion

TOKYO, Japan, Jan 30, 2026 - (JCN Newswire via SeaPRwire.com) - NTT DOCOMO, INC. and Aduna announced today that they concluded a partnership agreement (the “Agreement”) on January 29, 2026. This partnership enables DOCOMO's network Application Programming Interfaces (network APIs), developed for the international markets, to be made available through Aduna's platform. Together, the companies aim to accelerate the expansion of the global network API ecosystem in response to evolving industry demand.Providing mobile network capabilities through APIs has been gaining traction globally as an effective way for enterprises to address critical issues such as fraud prevention and secure digital authentication. Supported by the CAMARA*1 framework, Mobile Network Operators are developing and exposing standardized API solutions that address critical security needs. Aduna-acting as the global aggregator*2 for these standardized APIs-provides a single, centralized access point to multiple operators worldwide, helping to accelerate ecosystem adoption and simplify enterprise integration at scale.As part of its efforts to generate new revenue streams, DOCOMO has participated in the GSMA Open Gateway*3 initiative and, since June 2025, has been collaborating with Aduna to expand network API-based services through aggregation model.Through the Agreement, DOCOMO's advanced network APIs are expected to become accessible to enterprises and developers worldwide via Aduna's global platform. This collaboration aims to support fraud prevention strategies via APIs such as Number Verification and SIM Swap detection, thus enabling enterprises to protect customers from account takeovers, identity theft, and mobile fraud. The partnership also opens up additional routes for DOCOMO to reach new customer segments through global distribution.Leveraging DOCOMO's innovation and Aduna's global aggregation and distribution model, the companies intend to support broader adoption of network APIs and enable enterprises and developers to create new, value-driven services.Nobuko Hiraguchi, Senior Vice President and General Manager of the Core Network Design Department at NTT DOCOMO, commented: “We are delighted to enter into this partnership agreement with Aduna. By making NTT DOCOMO's network APIs-developed in alignment with global standards-available through Aduna's global platform, we are confident that this collaboration will help create new value that enhances the safety and comfort of each customer's daily life. NTT DOCOMO will continue to advance technical development, including network APIs, to deliver even greater value to society and our customers.”Anthony Bartolo, CEO of Aduna, commented: “Aduna was founded to help telecom operators such as DOCOMO transform standardization into real commercial value. By linking DOCOMO's advanced network APIs to a global distribution platform, we enable enterprises worldwide to innovate more quickly, securely, and at scale. This partnership strengthens Aduna's presence across the Asia region and reflects our shared commitment to accelerating the growth of the global Network API economy.”*1 The CAMARA Project is an open-source project under the Linux Foundation that develops common specifications for operator network APIs.*2 An aggregator is an entity that enables enterprises and developers to access standardized network APIs-offered by multiple mobile network operators-through a single unified platform.*3 GSMA Open Gateway is a global industry initiative launched by the GSMA to promote the commercialization of common network APIs across mobile operators.About NTT DOCOMONTT DOCOMO, Japan's leading mobile operator with over 91 million subscribers, is one of the global leaders in 3G, 4G and 5G mobile network technologies. Under the slogan “Bridging Worlds for Wonder & Happiness,” DOCOMO is actively collaborating with global partners to expand its business scope from mobile services to comprehensive solutions, aiming to deliver unsurpassed value and drive innovation in technology and communications, ultimately to support positive change and advancement in global society. https://www.docomo.ne.jp/english/About AdunaAduna is a landmark venture between some of the world's leading telecom operators and Ericsson, dedicated to enabling developers worldwide to accelerate innovation by leveraging networks to their full potential via common network Application Programming Interfaces (APIs). Its venture partners include AT&T, Bharti Airtel, Deutsche Telekom, KDDI, Orange, Reliance Jio, Singtel, Telefonica, Telstra, T-Mobile, Verizon, and Vodafone. Aduna's developer partner platforms include Google Cloud, Infobip, Sinch, and Vonage. By combining network APIs from multiple operators globally under a unified platform based on the CAMARA open-source project, driven by the GSMA and the Linux Foundation, Aduna provides a standardized platform to foster collaboration, enhance user experiences, and drive industry growth. To find out more about network APIs and Aduna, visit https://adunaglobal.com/. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

ACN Newswire

CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China

SHENZHEN, Jan 30, 2026 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by the Group on 22 April 2025 for details) received approval from the National Medical Products Administration of China (NMPA) on 30 January 2026 for the New Drug Application (NDA) of ruxolitinib phosphate cream (the “Product”) for the treatment of non-segmental vitiligo with facial involvement in children aged 12 years and older and adult patients. It is the first and only targeted drug approved in China for vitiligo, addressing a significant unmet clinical need.Ruxolitinib phosphate cream is the first and only drug approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for repigmentation in nonsegmental vitiligo[1,2]. Prior to receiving formal NDA approval, the Group benefited from the “Early and Pilot Implementation” policy granted to the Hainan Free Trade Port and Lecheng Pilot Zone (“Lecheng Pilot Zone”), the “Hong Kong and Macau Medicine and Equipment Connect” policy, and the clinically urgently needed imported drug policies of the Beijing and Tianjin Free Trade Zones, and had already initiated the pilot application of ruxolitinib phosphate cream. Currently, Boao Super Hospital has prescribed ruxolitinib phosphate cream to over 7,000 patients with non-segmental vitiligo, and more than twenty hospitals in Guangzhou, Shenzhen, Dongguan, Foshan, Zhongshan, Zhuhai, Jiangmen, Huizhou, Beijing and Tianjin have provided prescription services for the Product, demonstrating its clinical potential.The product has shown positive results in both overseas clinical studies and the real-world study in China: in two identical Phase III double-blind, randomized, placebo-controlled studies (TRuE-V1 and TRuE-V2) conducted overseas, the proportion of patients achieving the primary efficacy endpoint of at least 75% improvement in the Facial Vitiligo Area Score Index (F-VASI 75) after 24 weeks of treatment with ruxolitinib phosphate cream was 29.9% in both studies, significantly higher than the 7.5% and 12.9% in the placebo groups, respectively. Continued use up to 52 weeks showed sustained repigmentation[3]. In accordance with the relevant regulations of the Lecheng Pilot Zone's real-world data application pilot project, ruxolitinib phosphate cream underwent real-world study in China, demonstrating positive efficacy consistent with the results of overseas pivotal clinical studies. All secondary efficacy endpoints in both domestic and overseas clinical studies showed a benefit trend consistent with the primary efficacy endpoint, and the treatment effect for vitiligo continued to improve with prolonged treatment. Furthermore, according to safety monitoring data from the Lecheng Pilot Zone, no new safety event was identified, no adverse event (AE) leading to discontinuation or withdrawal of treatment occurred, and no study drug-related serious adverse event (SAE) occurred.This approval in vitiligo brings new hope for treatment to over 10 million vitiligo patients in China, addressing urgent clinical needs. At the same time, it will add to Dermavon’s product portfolio in the field of skin treatment, potentially synergizing with Dermavon’s commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream), and a series of innovative drugs under development and dermatological skin care products, in terms of expert network and market resources, thereby potentially enhancing Dermavon's position in the field of skin health.Furthermore, the Phase III clinical trial in China of ruxolitinib phosphate cream for the treatment of mild to moderate atopic dermatitis (AD) has achieved positive results. Currently, the Group is actively advancing the NDA for ruxolitinib phosphate cream for the treatment of AD in China, which, if approved, will provide a new treatment option for a broader patient population with AD in China.About VitiligoVitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[4]. Existing therapies, such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs), have clinical limitations, with adverse reactions or limited efficacy with long-term use. The NDA approval of ruxolitinib phosphate cream successfully fills the gap in targeted drug treatment for vitiligo and is of great landmark significance.More About Ruxolitinib Phosphate CreamRuxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte, is approved for the topical treatment of nonsegmental vitiligo in adult and patients aged 12 years and older, and for the short-term and non-continuous chronic treatment of mild to moderate AD in patients aged 2 years and older without immunodeficiency in the U.S. In Europe, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.The Group, through a subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside Mainland China to the Group (excluding Dermavon and its subsidiary).Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream, marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development  of the Group.Reference:1. The U.S. FDA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream2. The EMA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar3. The clinical studies information can be found on the Opzelura® official website, as follows:https://www.opzelura.com/opzelura-prescribing-information4. China Insights Consultancy’s industrial reportCMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Latest News

特朗普政府在重大军事援助谈判前将以色列称为“美国的模范盟友”

(SeaPRwire) -   上周，战争部长皮特·赫格斯思（Pete Hegseth）发布了《2026年国家防务战略》（NDS）——这一五角大楼的蓝图将 提升为“模范盟友”，并将唐纳德·特朗普总统的国家安全理念转化为具体的军事政策。“长期以来，以色列已证明，在得到美国关键但有限的支持下，它既有意愿也有能力自卫。以色列是模范盟友，我们现在有机会在特朗普总统为中东和平所做的历史性努力基础上，进一步增强其自卫能力，推动我们的共同利益，” 表示。该文件目前正影响着两场并行的辩论：一是美国对以色列安全援助的未来，二是在一些反对声音将这一联盟描述为负担而非战略资产的情况下，下一份《谅解备忘录》（MOU）是否应继续向以色列提供传统的美国军事援助。根据该战略，在10月7日的袭击事件后，以色列证明了其自卫的能力和意愿，表明它不是被动的伙伴，而是一支支持美国在该地区利益的作战力量。该战略强调赋能有能力的盟友而非限制它们，这是在特朗普总统早些时候通过 推动区域一体化的基础上进行的。美国犹太国家安全研究所（Jewish Institute for National Security of America）外交政策主任乔纳森·鲁赫（Jonathan Ruhe）表示，该战略反映了美国更广泛的转变——转向能同时加强美国安全和国内产业的伙伴关系。“谅解备忘录中的 资金以美元形式用于美国国内，支持我们的产业，” 鲁赫告诉 Digital。“正如国家安全战略中所说，这随后使以色列能够采取更多行动保护美国利益。”他表示，未来的协议可能不仅仅局限于资金。“新的谅解备忘录可能会更广泛，包括更多50对50的伙伴关系内容，比如联合研发、联合生产、情报共享等，以反映未来不断变化的伙伴关系，” 鲁赫说。该战略还强调了振兴美国国防工业基础的重要性，指出盟友购买美国系统有助于加强国内生产，同时让伙伴承担更多区域安全责任。以色列智库Mind Israel副总裁阿夫纳·戈洛夫（Avner Golov）表示，该文件明确表明，以色列不仅仅被视为援助接收国：“以色列正在战斗。我们自己保护自己。我们只是需要工具来做到这一点。通过这样做，我们不仅提升了美国在中东的地位，也提升了其在全球的地位，并为美国经济做出贡献。”这一框架出台之际，以色列和美国正准备就下一份为期10年的《谅解备忘录》进行谈判，该备忘录管理着美国对以色列的军事援助。目前的协议签署于2016年，每年提供33亿美元的外国军事融资，以及每年5亿美元的导弹防御合作资金。这场辩论源于拜登政府时期的紧张局势——2024年5月，白宫暂停向以色列交付某些美国武器，包括一批2000磅的炸弹。当时，内塔尼亚胡警告称，如果华盛顿停止武器交付，以色列“将孤军奋战”，这反映出对美国军事支持的限制或延迟可能削弱以色列的战备状态和威慑力的担忧。专家指出，美国领导人并非总是批准以色列的每一项武器请求，且以色列约70%的军事进口来自美国，这突显了内塔尼亚胡总理最近推动更大规模自主生产背后的战略考量。戈洛夫批评了这种做法，认为它可能将表面形象置于战备状态之上。“我认为这是短视的，” 戈洛夫说。“从长远来看，以色列必须首先为下一轮升级做好准备。如果我们没准备好，就会面临另一场战争；如果准备好了，或许能威慑住。”“以色列必须保持该地区最强大军队的地位，这也是美国的根本利益，” 戈洛夫说。鲁赫表示，这场辩论反映了近两年来战争的教训。“现在的情况有点颠倒：以色列人说不想再要美国的钱，而美国人说‘不，你们得要我们的钱’，” 他说。鲁赫称，这场冲突暴露了对美国供应链的严重依赖和政治拖延所造成的脆弱性。“过去两年的战争表明，以色列不能再如此依赖美国，也不能继续维持现有的国防伙伴关系，因为这会造成依赖，” 他说。“以色列会因美国武器产量短缺或出于政治动机的禁运和拖延而变得脆弱，这些都可能影响其战备状态。”同时，鲁赫指出，以色列在主要平台上仍依赖美国。“就连以色列也会说，我们在这些大额平台上完全依赖美国，” 他说，并举出以色列已承诺购买的F-15和F-35等飞机为例。因此，鲁赫认为，维持 可能是最现实的前进道路。“对国会来说，直接批准这笔钱实际上容易得多，” 他解释说，可预测的资金能减少国会山每年的政治斗争。戈洛夫表示，以色列的长期目标不应是减少与华盛顿的联系，而是深化这种联系。“我不想减少依赖，” 他说。“我想增加对美国的贡献。”他将这一新兴愿景描述为联盟结构的根本性转变。“我们正从20世纪的援助模式转向21世纪的战略合并，” 戈洛夫说。“以色列是唯一一个无需美国派遣一兵一卒就能带来400%投资回报的伙伴。”戈洛夫表示，拟议的框架围绕三大支柱构建：国防工业生态系统、联合技术生态系统，以及连接以色列创新、海湾基础设施和美国力量的区域生态系统。他强调，在过渡期间维持美国的安全援助至关重要。“我们需要与当前的安全援助《谅解备忘录》达成最后一个为期十年的‘过渡桥梁’，” 戈洛夫说。“突然切断援助将向我们的敌人发出美国退缩的危险信号，可能阻碍以色列国防军（IDF）的战备状态。”“我不知道下一任美国总统是谁，” 他补充道。“但我们的敌人可能会以非常危险的方式解读这一点。”本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

SeaPRwire

上山有多值得？ 一间让星马港客爱上台中的无菜单餐厅

2026年1月30日 - (SeaPRwire) - 当自由行旅客在台中想找一间「值得专程上山」的餐厅，很多新加坡、马来西亚与香港旅人会把答案指向同一个地方：台中新社半山腰的无菜单料理餐厅「飞花落院」。最近，飞花落院也登上网络节目《上课了！地缘经济学》专访，再次把这间「不用报地址、计程车司机也知道」的名店推上话题焦点。飞花落院创办人魏幸怡受访时表示，海外旅客喜欢飞花落院不只是因为美食，关键更在于「你会经历什么」：一段上山看景、入席变得优雅、在庭院里把时间慢下来的旅程。 上山吃一餐，也把台中夜景与日式庭园一次打包 飞花落院位在海拔四百多公尺的新社，白天可俯瞰台中城市景，夜晚更是百万夜景等级；加上日式庭园、包厢氛围与大量回收木材打造的空间细节，让不少星马、香港旅客形容「很像把京都的静，和台湾山城的景放在同一张明信片里」。而节目中最让观众惊呼的细节，则是「燕子住得比谁都久」。 魏幸怡分享，飞花落院命名源自唐诗苏颋〈山驿闲卧即事〉名句：「息燕归檐静，飞花落院闲。」巧的是，建造期间燕子真的飞来筑巢、还生了小燕子，团队因此停工等待并保留燕巢至今。她笑说：「它是我们这里住最久的居民，也带来很多福气和缘分。」这段故事也成为海外旅客最爱拍照、最爱分享的「只有飞花落院才遇得到」的记忆点。 在地食材＋国际主厨，把台湾最好的食材端上世界餐桌 在料理上，飞花落院以无菜单形式呈现，让每次到访都像开盲盒，但惊喜背后其实很有脉络：一端是土地，一端是国际。魏幸怡指出，餐厅会把新社菇类、大坑竹笋，以及水井地区特别适合生长的根茎作物做成「在地三重奏」；海味则与宜兰大溪渔港渔夫合作，渔获不进拍卖市场，直接在船上挑好、定期直送厨房，把最新鲜的状态交给料理。 她也观察，许多新加坡、香港旅客其实最想听的，是台湾食材背后的故事：这块土地原本是一片竹林、如何保留原始树木、为什么空间大量使用竹子向土地致敬。于是飞花落院把「说故事」变成餐桌的一部分，让海外旅客不只吃到台湾，还能「听懂台湾」。 节目中也呈现飞花落院的国际视野。来自意大利、旅居日本金泽的客座主厨 Matteo，将意大利的灵魂、日本的细腻与台湾山海食材做创意结合；他形容台湾的山与海，让他想起意大利与日本的风土相似，因此更能用自己的语言读懂台湾味。甜点更把「只有台湾才有的惊喜」端上桌，例如以莲雾入甜点，搭配贵妃乌龙与接骨木花糖浆，现点现做、香气堆叠，让不少海外旅客直呼「这个在海外很少吃得到」。 魏幸怡也坦言，飞花落院一路走来并非没有挑战。早期台中市场平均客单价多落在千元上下，飞花落院一开始就设定在三千元以上，必须用时间让客人理解「看不见的用心」：食材挑选、料理设计、空间与服务的完整性。如今，餐厅累积了不少回访三、四十次的熟客，也成为星马、香港旅客愿意专程把新社排进行程的理由，因为他们买到的不是「吃饱」，而是一段被认真款待的旅行片段。欢迎喜爱四季更迭的你到飞花落院走走：https://www.inflorescence.com.tw/

ACN Newswire

SuperX Commences Production at First Global Supply Center

OSAKA, Japan, January 30, 2026 - (ACN Newswire via SeaPRwire.com) - SuperX AI Technology Limited (NASDAQ: SUPX) ("the Company" or "SuperX"), an emerging AI Data Center infrastructure solutions provider, today announced the official start of production at its newly established SuperX Global Supply Center in Japan. Located in Tsu City, Mie Prefecture, Japan, this facility represents SuperX’s primary supply hub. The commencement of production at this facility marks the Company's transition from engineering and preparation to scaled commercial production. Located in Japan, this center is established to serve SuperX’s global customer base.Strategic Rationale & Operational FocusSuperX selected Japan for its first supply center to integrate Japan’s established industrial capabilities with SuperX’s technical expertise. The center focuses on three pragmatic objectives:Manufacturing Quality: Leveraging Japan’s rigorous execution standards to ensure high reliability for high-performance AI servers.Production Scale: The facility is currently capable of delivering up to 20,000 AI servers annually, providing the capacity needed to fulfill immediate demand, and expandable to fulfil future global orders.Global Export: Serving as a consolidated hub for system integration and logistics, streamlining delivery to international markets.Market ProgressThe commencement of production at the SuperX Global Supply Center supports the Company’s immediate commercial execution. In January, 2026, SuperX has secured customer purchase orders with an estimated total value of USD 910 million. Separately, the Company has also entered into MOUs with several potential customers for the purchase of 5,000 units of AI servers within the next 12 months, with an estimated total order value of up to USD 2.1 billion.Globalized Support ServicesTo better support customers through AI server product deployment and post-sales services, SuperX is rolling out a standardized technical service system, including 24/7 response via a global support center based in Singapore, expert-level technical support, and end-to-end services. For domestic Japanese delivery and operations, SuperX combines a global technical team with a local spare-parts network. This enables customizable project implementation services, and tiered SLA-backed on-site maintenance options to support rapid go-live and stable operation. Executive Commentary"This is a foundational moment for SuperX," said Dr. Chenhong Huang, Chairman and CEO of SuperX. "By establishing our first SuperX Global Supply Center in Japan, we are securing the engineering discipline and quality assurance required to compete on a global stage. This facility allows us to control our production standards and deliver reliable, full-stack AI solutions to our customers worldwide."About SuperX AI Technology Limited (NASDAQ: SUPX) SuperX AI Technology Limited is an AI infrastructure solutions provider, offering a comprehensive portfolio of proprietary hardware, advanced software, and end-to-end services for AI data centers. The Company's services include advanced solution design and planning, cost-effective infrastructure product integration, and end-to-end operations and maintenance. Its core products include high-performance AI servers, 800 Volts Direct Current (800VDC) solutions, high-density liquid cooling solutions, as well as AI cloud and AI agents. Headquartered in-Singapore, the Company serves institutional clients globally, including enterprises, research institutions, and cloud and edge computing deployments. For more information, please visit:www.superx.sg Safe Harbor Statement This press release may contain forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The reader is cautioned not to rely on these forward-looking statements. The forward-looking events discussed in this press release, including quantities and estimated value of orders and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. The quantities and estimated order value mentioned in the MOUsA are non-binding and subject to the execution of purchase orders and definitive agreements . Actual delivery schedules and value of AI servers may vary based on customer data center readiness and supply chain conditions. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur. Follow our social media: X.com:https://x.com/SUPERX_AI_  LinkedIn:https://www.linkedin.com/company/superx-ai  Facebook:https://www.facebook.com/people/Super-X-AI-Technology-Limited/61578918040072/# Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ACN Newswire

From Digitization to AI Computing: Cheche Group Inc. (CCG) Partners with Volkswagen DSSO and Cardif Airstar Insurance to Usher in the “Premium Era” of Advanced Smart Driving Insurance

HONG KONG, January 30, 2026 - (ACN Newswire via SeaPRwire.com) – As China’s first batch of Level 3 (L3) conditionally autonomous driving vehicles receives official market access, advanced smart driving is poised for its inaugural year of commercial explosion. At this pivotal juncture, Cheche Group Inc. (CCG) ("Cheche" or the "Company"), a leading global InsurTech platform, announced the signing of a strategic cooperation agreement with Volkswagen (Anhui) Digital Sales and Services Co., Ltd. (hereinafter "DSSO") and Beijing Cardif Airstar Property & Casualty Insurance Co., Ltd. (hereinafter "Cardif Airstar Insurance").This tripartite collaboration is more than just a deep dive into high-quality growth for New Energy Vehicle (NEV) insurance; it represents a core transition from "digitization" to "intelligence." The partnership establishes three strategic directions for synergy. First, it focuses on the transformation of product formats by leveraging Cheche’s SaaS platform to co-create an integrated "Insurance + Value-Added Services" package, enabling the efficient, one-stop fulfillment of high-value services. Second, it upgrades pricing capabilities by deeply integrating compliant driving data with dynamic vehicle information, utilizing AI-driven risk profiling to achieve differentiated precision pricing while addressing the complex challenge of liability determination in human-machine co-driving scenarios. Finally, it expands the ecosystem dimension by embedding insurance services throughout the vehicle sales and after-sales process, extending the business from a single policy to a full-lifecycle service ecosystem that encompasses renewal management and mobility protection.01. Smart Driving Insurance: Securing "Pricing Authority" in the L3 Mass Production EraTraditional auto insurance has long struggled with "human-machine co-driving" scenarios due to a lack of real-time dynamic data for liability determination and precise risk identification. Having served leading automakers such as Tesla, Li Auto, and Xiaomi, Cheche provides VW Anhui Digital with an embedded SaaS system centered on data attribution and dynamic pricing.Through this SaaS infrastructure, vehicle driving data is seamlessly synchronized with BNP Paribas Star’s actuarial models. This AI-driven joint risk profiling not only resolves the technical difficulties of liability judgment in smart driving scenarios but also delivers a "low-premium rewards for safe drivers," serving as a vital solution to the profitability challenges currently facing the NEV insurance industry.02. Ecosystem Breakthrough: Leveraging the "Xiaomi + Volkswagen DSSO" New Quality Productive ForcesInvestors are closely watching the cross-sector dynamics underpinning this collaboration. Cardif Airstar Insurance was co-founded by Xiaomi Group, Volkswagen Financial Services, and Cardif Airstar Insurance, combining the strengths of an internet giant, a global financial powerhouse, and a leading smart automaker.As the hub connecting these forces with Volkswagen’s Hefei Intelligent Electric Vehicle Center, Cheche is penetrating the world’s top smart driving supply chains. This is not merely system integration; it marks Cheche’s evolution into a digital operator within the "Vehicle-Battery-Charging-Insurance" integrated landscape. Amid policy tailwinds such as "New Quality Productive Forces," Cheche’s closed-loop ecosystem is becoming a definitive growth pole for insurance and tech capital.03. Scenario Transformation: From Transactional Policies to Full-Lifecycle OperationsIn 2026, as the automotive market shifts from a competition over hardware parameters to a competition over user experience, Cheche is helping DSSO deeply couple insurance services with the car-buying and after-sales journey. The integrated service package transforms insurance from a low-frequency tool into a high-frequency touchpoint for user engagement.Christian Koenig, After-sales Director of DSSO, noted that Cheche’s technical foundation allowed the partnership to advance rapidly from a high starting point. This "plug-and-play" empowerment capability, proven by mainstream automakers, has become a technical moat for Cheche in the capital markets.04. Conclusion: The Final Piece of the Trillion-Dollar Blue OceanThe year 2026 marks the point where NEV insurance evolves from scale expansion to intelligent upgrades. Cheche will continue to advance its AI pricing engine, driving the leap from digital to intelligent services.According to data released by the Ministry of Public Security on January 26, China’s NEV ownership reached 43.97 million units by the end of 2025, accounting for 12.01% of the total vehicle population—a growth rate exceeding 40% year-over-year. In this environment, those who define the insurance standards for the smart driving era will control the entry point to future mobility. With its high barriers to entry via OEM partnerships and forward-looking AI layouts, Cheche is racing toward becoming a leader in the trillion-dollar NEV insurance market. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ACN Newswire

Nissin Foods (Hong Kong) Charity Fund Supports Elite Athletes from The Education University of Hong Kong for the Fourth Consecutive Year

HONG KONG, January 30, 2026 - (ACN Newswire via SeaPRwire.com) – 27 January 2026, Nissin Foods (Hong Kong) Charity Fund (“Charity Fund”) announced its continued support for elite athletes from The Education University of Hong Kong (“EdUHK”) for the fourth consecutive year. The Presentation Ceremony for the Nissin Foods Scholarship for Elite Athletes 2025/2026 was held to honour seven outstanding athletes who not only demonstrate excellence in their respective sports but also aspire to become future educators. The scholarship will cover their full tuition fees throughout their entire study period, enabling them to pursue their academic and athletic goals without financial concerns.Established in 2022 by the Nissin Foods (Hong Kong) Charity Fund, the scholarship is designed to encourage elite athletes enrolled in the Bachelor of Health Education (Honours), Bachelor of Science (Honours) in Sports Science and Coaching, or the Postgraduate Diploma in Education programme at EdUHK. The initiative aims to support their dual career development, empowering them to become qualified health educators while continuing to strive for excellence in their athletic performance.The seven awardees for the 2025/2026 academic year include new and renewing recipients. The four new awardees are: Mr. MOK Pak Fan (triathlon), Mr. WONG Pak Yiu (triathlon), Miss HO Kin Yiu (volleyball), and Miss YAN Nuo (shuttlecock). In addition to welcoming new scholars, the Charity Fund also made the scholarship renewable to support the elite athletes throughout their study period. The three recipients of the renewed scholarship are: Mr. CHOI Kwan Lok (cycling, retired), Mr. CHEN Pak Hong (rowing), and Mr. Joseph LAU (cycling).Mr. Kiyotaka ANDO, Chairman of Nissin Foods (Hong Kong) Charity Fund, said, “Having been deeply rooted in Hong Kong for over four decades, Nissin Foods is steadfast in its mission to give back to the community. This scholarship is a direct reflection of our founder Mr. Momofuku Ando’s philosophy that ‘Eating and sports are the two axles of health.’ By supporting these talented athletes at EdUHK for the fourth year, we are not just providing financial support, we are investing in future leaders who will champion health and wellness in our society. We are proud to empower them on their dual career path, confident that they will inspire the next generation as both accomplished athletes and dedicated educators.”Expressing his profound gratitude for the long-standing partnership, Professor Chetwyn CHAN, Vice President (Research and Development) of EdUHK, said, “EdUHK is dedicated to promoting sustainable dual-career pathways for high-performance athletes. The generous Nissin Foods Scholarship for Elite Athletes allows us to support both active and retired athletes in advancing their educational pursuits, while also recognising their exceptional sporting accomplishments. I would like to extend my heartfelt congratulations to all the scholarship recipients, who demonstrated great passion, determination, and a sense of mission, and sincerely thank the Nissin Foods (Hong Kong) Charity Fund, and Mr Ando for the tremendous support and confidence in health education and the development of elite athletes.”Accomplished volleyball player Miss HO Kin Yiu, recipient of the scholarship from the Postgraduate Diploma in Education, majoring in Chinese and Physical Education, shared her heartfelt appreciation to the Charity Fund, “The support of the scholarship empowers us, as elite athlete-students, to chase our aspirations and make a meaningful influence on society. We are confident that we can help create a brighter future through the spirit of sports and education.”PhotoMr. Kiyotaka ANDO, Chairman of Nissin Foods (Hong Kong) Charity Fund (middle right), and Professor Chetwyn CHAN, Vice President (Research and Development) of EdUHK (middle left), attended the Presentation Ceremony for Nissin Foods Scholarship for Elite Athletes 2025/2026 on 27 January 2026. Five scholarship recipients attended the ceremony, including four new awardees for the 2025/2026 academic year, namely: (from left to right) Mr. MOK Pak Fan, Mr. WONG Pak Yiu, Miss HO Kin Yiu, and Miss YAN Nuo, as well as the renewed awardee - Mr. CHOI Kwan Lok. Awardees of the Nissin Foods Scholarship for Elite Athletes 2025/2026 are achieving great success in their individual disciplines. From top left: Mr. WONG Pak Yiu (triathlon), Miss HO Kin Yiu (volleyball), Mr. MOK Pak Fan (triathlon), Miss YAN Nuo (shuttlecock), Mr. CHOI Kwan Lok (cycling, retired), Mr. CHEN Pak Hong (rowing), and Mr. Joseph LAU (cycling).About Nissin Foods (Hong Kong) Charity FundThe Nissin Foods (Hong Kong) Charity Fund (“Charity Fund”) was set up in September 2020 by way of a trust deed by Nissin Foods Company Limited (Stock code: 1475). The objectives of the Charity Fund are: a) to advance education, teaching, learning, arts, science and academic research; b) to make provision for people in need; and c) to carry out works of a charitable nature that are beneficial to the Hong Kong community. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

EQS Newswire

中国联通荣获中国证券“金紫荆奖”

EQS via SeaPRwire.com / 2026-01-30 / 15:29 UTC+8 (2026年1月30日，香港) – 2026年1月30日，第十五届香港国际金融论坛暨中国证券“金紫荆奖”颁奖典礼在香港举行。该活动由香港大公文汇传媒集团联合香港中国企业协会、香港中国金融协会、香港中资证券业协会、香港公司治理公会共同主办，是两地资本市场具有广泛影响力的公开评选活动。   中国联合网络通信（香港）股份有限公司(港交所编号：762)在此次评选中荣获“卓越上市公司”“卓越投资者关系管理上市公司”两项荣誉，公司香港办公室主任陈树雄代表领奖。   此次获奖，是资本市场对公司过去一年在市值表现、投资者关系、信息披露、企业治理、环境及社会责任等领域的认可。         作为记录产业变革、促进两地资本市场沟通的重要平台，荣获“金紫荆奖”将成为公司高质量发展前行的动力。未来，公司将坚持“守正创新、行稳致远”主基调，以“连接”“算力”“服务”“安全”为核心赛道，不断健全市值管理长效机制，深化分类差异化投资者关系管理，持续提升合规信息披露水平，为股东、客户、员工及社会创造更大价值。     －完－   媒体垂询： 中国联合网络通信（香港）股份有限公司 综合部 陈帅先生 电话：(852) 2121 3212 电邮：chris@chinaunicom.com.hk     2026-01-30 此财经新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php

ACN Newswire

康哲药业（867.HK/8A8.SG）：磷酸芦可替尼乳膏获批 为中国批准的首款且唯一白癜风靶向药

深圳, 2026年1月30日 - (亚太商讯 via SeaPRwire.com) - 康哲药业控股有限公司 （"康哲药业"）欣然宣布，旗下德镁医药有限公司（"德镁医药"，专业聚焦皮肤健康的创新型医药企业，正申请于香港联合交易所有限公司主板独立上市，详见康哲药业日期为2025年4月22日发布的公告）已于2026年1月30日获得中国国家药品监督管理局（NMPA）批准磷酸芦可替尼乳膏（白癜风适应症）（"产品"）新药上市许可申请（NDA）。产品用于治疗12岁及以上儿童和成人患者伴面部受累的非节段型白癜风，是中国批准的首款且唯一用于白癜风治疗的靶向药，满足巨大未被满足的临床需求。磷酸芦可替尼乳膏是经美国食品和药物管理局（FDA）及欧洲药品管理局（EMA）批准的首款也是唯一一款用于非节段型白癜风复色的药物[1,2]，在产品正式获得NDA批准之前，康哲药业受益于国家赋予海南自由贸易港及乐城先行区（"乐城先行区"）"先行先试"政策、"港澳药械通"政策、北京市及天津自贸试验区的临床急需进口药品政策，已启动磷酸芦可替尼乳膏的试点应用。目前博鳌超级医院已为超7,000名非节段型白癜风患者开具磷酸芦可替尼乳膏处方，且广州、深圳、东莞、佛山、中山、珠海、江门、惠州、北京及天津共二十余家医院已提供该药品处方服务，体现了其临床价值。产品在境外临床研究与中国真实世界研究中均展现出积极结果：其在境外开展的两项相同设计的III期双盲、随机、安慰剂对照研究（TRuE-V1和TRuE-V2）中，产品治疗24周后达到主要疗效指标面部白癜风面积评分指数改善至少75%（F-VASI 75）的患者比例均为29.9%，显著高于安慰剂组的7.5%和12.9%，持续使用至52周，复色效果持续[3]。根据乐城先行区药品真实世界数据应用试点项目有关规定，磷酸芦可替尼乳膏在中国开展真实世界研究，疗效积极，与境外关键临床研究结果一致。境内外临床研究中所有的次要疗效指标均显示出与主要疗效指标一致的获益趋势，且白癜风治疗效果随疗程延长持续改善。同时，根据乐城先行区安全性监测数据，未发现新的安全性事件，未发生导致停药或退出的不良事件（AE），未发生研究药物相关的严重不良事件（SAE）。此次产品白癜风适应症获批，将为国内千万白癜风患者带来治疗新希望，满足市场迫切的临床需求。同时，产品将进一步丰富德镁医药在皮肤治疗领域的产品矩阵，并有望与现有处于商业化阶段的创新药益路取（替瑞奇珠单抗注射液）、独家药喜辽妥（多磺酸粘多糖乳膏），以及系列在研创新药和皮肤学级护肤品等在专家网络与市场资源等方面产生协同，提升德镁医药在皮肤健康领域的地位。此外，康哲药业于中国开展的磷酸芦可替尼乳膏治疗轻中度特应性皮炎患者的III期临床试验，已取得阳性结果。截至目前，康哲药业正在中国积极推进磷酸芦可替尼乳膏治疗特应性皮炎的新药上市申请，如若获批上市，将为中国广大特应性皮炎患者群体提供新的治疗选择。关于白癜风适应症白癜风是一种慢性自身免疫性疾病，其特征是皮肤色素脱失，其发病原因为产生色素的细胞即黑素细胞的缺失。据估算，中国约有1030万人患有白癜风，其中约820万人患有非节段型白癜风[4]。现有疗法，如外用糖皮质激素（TCS）及外用钙调神经磷酸酶抑制剂（TCIs）存在临床缺陷，长期用药有不良反应或疗效有限。磷酸芦可替尼乳膏NDA获批，成功填补了白癜风靶向药物治疗的空白，具有重大标志性意义。关于磷酸芦可替尼乳膏的更多信息磷酸芦可替尼乳膏（Opzelura®）是Incyte开发的选择性JAK1/JAK2抑制剂芦可替尼制成的一种创新型乳膏，在美国获批用于局部治疗成人及12岁及以上患者的非节段型白癜风，及2岁及以上非免疫力功能低下患者的轻度至中度特应性皮炎的局部短期和非连续性慢性治疗。在欧洲，磷酸芦可替尼乳膏被批准用于治疗成年及12岁及以上青少年面部受累的非节段型白癜风。康哲药业于2022年12月2日，通过德镁医药的附属公司与Incyte就磷酸芦可替尼乳膏订立合作和许可协议（"许可协议"），获得在中国大陆、香港特别行政区、澳门特别行政区、台湾地区及东南亚十一囯（"区域"）研发、注册及商业化产品的独家许可权利，以及在区域内生产产品的非独家许可权利。德镁医药的附属公司已将磷酸芦可替尼乳膏除中国大陆外的其他区域的相关权利再许可予康哲药业（不包括德镁医药及其附属公司）。Incyte拥有磷酸芦可替尼乳膏全球开发和商业化权利，在美国及欧洲以Opzelura®的名称销售。Opzelura®和Opzelura®标识是Incyte的注册商标。关于康哲药业康哲药业是一家链接医药创新与商业化，把控产品全生命周期管理的开放式平台型企业，致力于提供有竞争力的产品和服务，满足尚未满足的医疗需求。康哲药业专注于全球首创（FIC）及同类最优（BIC）的创新产品，并高效推进创新产品临床研究开发和商业化进程，赋能科研成果向诊疗实践的持续转化，造福患者。康哲药业聚焦专科领域，拥有被验证的商业化能力，广泛的渠道覆盖和多疾病领域专家资源，核心在售产品已获领先的学术与市场地位。康哲药业围绕优势专科领域不断纵深发展，以巩固心脑血管/消化/眼科/皮肤健康业务竞争力，带来专科规模效率，其中皮肤健康业务（德镁医药）已成为其细分领域的龙头企业，并拟于联交所独立上市。同时，康哲药业持续推动研产销全产业链在东南亚及中东区域运营发展，以获取新兴市场的增量，助力集团实现高质量可持续发展。参考文献/资料1.FDA批准信息可在Incyte官网查询，网址：https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream2.EMA批准信息可在Incyte官网查询，网址：https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar3.相关临床研究信息可在Opzelura®官网查询，网址：https://www.opzelura.com/opzelura-prescribing-information4.数据来自灼识咨询报告康哲药业免责与前瞻性声明本新闻无意向您做任何产品的推广，非广告用途。本新闻不对任何药品和-医疗器械和/或适应症作推荐。若您想了解具体疾病诊疗信息，请遵从医生或其他医疗卫生专业人士的意见或指导。医疗卫生专业人士作出的任何与治疗有关的决定应根据患者的具体情况并遵照药品说明书。由康哲药业编制的此新闻不构成购买或认购任何证券的任何要约或邀请，不形成任何合约或任何其他约束性承诺的依据或加以依赖。本新闻由康哲药业根据其认为可靠之资料及数据编制，但康哲药业并无进行任何说明或保证、明述或暗示，或其他表述，对本新闻内容的真实性、准确性、完整性、公平性及合理性不应加以依赖。本新闻中讨论的若干事宜可能包含涉及康哲药业的市场机会及业务前景的陈述，该等陈述分别或统称为前瞻性声明。该等前瞻性声明并非对未来表现的保证，存在已知及未知的风险、不明朗性及难以预知的假设。康哲药业并不采纳本新闻包含的第三方所做的任何前瞻性声明及预测，康哲药业对该等第三方声明及预测不承担责任。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ACN Newswire

Formerra to Supply Foster Medical Compounds in Europe

PUTNAM, CT AND ROMEOVILLE, IL, Jan 29, 2026 - (ACN Newswire via SeaPRwire.com) - Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials."Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications."Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.Key DetailsFormerra will distribute Foster® medical compounds in Europe.This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.About FormerraFormerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.About GEON Performance SolutionsGEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.Media ContactJackie MorrisMarketing Communications Manager, Formerrajackie.morris@formerra.com+1 630-972-3144SOURCE: Formerra Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ACN Newswire

Shoucheng Holdings’ Robotics Portfolio Gains Visibility as AI and Automation Take the Stage at China’s 2026 CMG New Year’s Gala

HONG KONG, January 30, 2026 - (ACN Newswire via SeaPRwire.com) – A growing number of robotics and artificial intelligence companies backed by Shoucheng Holdings Limited are set to appear at China’s 2026 CMG New Year’s Gala, reflecting the investor’s expanding footprint across the country’s emerging automation and embodied intelligence sectors.The latest company to confirm its participation is Noetix Robotics, according to recent announcements. Shoucheng Holdings led the company’s financing round in 2024 and has continued to increase its investment through subsequent rounds, making it Noetix Robotics’ largest external investor, people familiar with the matter said.Noetix Robotics’ appearance adds to a lineup that already includes other Shoucheng-backed firms. Unitree Robotics, known for its quadruped and humanoid robots, was earlier named a robot partner of the 2026 Gala, marking its third appearance on the program. Beijing Galbot Co., Ltd., which focuses on embodied artificial intelligence systems, has also been designated by China Media Group as the Gala’s embodied large-model robot.The clustering of multiple portfolio companies on the same edition of the Gala places Shoucheng Holdings among a small group of investors with broad representation on one of China’s most-watched annual broadcasts. The event, which regularly draws hundreds of millions of viewers, has increasingly been used as a platform to highlight advances in artificial intelligence, robotics and advanced manufacturing.China Media Group, the organizer of the Gala, has in recent years expanded the role of technology-focused programming, aligning with national policy priorities around intelligent manufacturing and industrial upgrading. While participation in the Gala does not directly translate into revenue, companies and investors see it as an important signal of technical maturity and policy relevance.Unitree Robotics’ repeated appearances underscore this dynamic. The company has previously used the Gala to demonstrate improvements in motion control, balance and coordination, capabilities that are critical as robots move from laboratory environments into commercial and industrial settings. Its continued inclusion suggests confidence in its engineering progress and deployment readiness.Galbot’s designation as the Gala’s embodied large-model robot reflects a broader shift in focus from mechanical performance alone to systems that integrate perception, reasoning and physical execution. Embodied artificial intelligence—where large models are combined with real-world robotic interaction—has become a priority area for Chinese research institutions and technology companies as generative AI expands beyond software applications.The addition of Noetix Robotics introduces another layer to the lineup. The company concentrates on robotic power systems and core engineering components, segments that are increasingly viewed as strategic as China seeks to reduce reliance on imported technologies and strengthen domestic supply chains. Shoucheng Holdings’ sustained backing of Noetix Robotics highlights an investment strategy that spans both complete robotic systems and foundational hardware.Shoucheng Holdings has steadily increased its exposure to robotics over the past several years, backing companies involved in full-stack robotics, embodied intelligence and critical components. Rather than focusing on a single technological approach, the firm has adopted a portfolio strategy that combines capital investment with access to application scenarios and commercialization platforms.One such platform is the Shoucheng Robot Tech Experience Store, a robotics-focused retail and demonstration network operated by the company. While not all Gala participants are Shoucheng investees, some companies, including MagicLab Robotics Technology (Wuxi) Co., Ltd., have placed products such as robotic dogs within the platform’s offline spaces for demonstrations and user engagement. MagicLab was named a strategic intelligent robotics partner for the Year of the Horse CMG New Year’s Gala earlier this year.By linking high-profile media exposure with physical demonstration and sales environments, Shoucheng Holdings aims to accelerate the transition from technology showcase to market adoption, according to people familiar with the platform’s positioning. The approach mirrors a broader trend among Chinese industrial investors to combine financial backing with scenario-based deployment.Industry analysts say the concentration of Shoucheng-backed companies on the 2026 Gala stage illustrates how China’s robotics sector is evolving from isolated prototypes toward more integrated industrial ecosystems. The presence of companies spanning full robotic platforms, embodied intelligence and core engineering components suggests increasing specialization and coordination across the value chain.As preparations for the 2026 CMG New Year’s Gala continue, robotics and artificial intelligence are expected to remain central themes. For Shoucheng Holdings, the event offers a snapshot of how its investments are converging on a national platform, reflecting a strategy that has shifted from selective bets to a broader, system-oriented approach to industrial technology.While the commercial impact of Gala exposure is difficult to quantify, market participants increasingly view the lineup as an indicator of which technologies and companies are gaining momentum within China’s rapidly changing AI and automation landscape. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ACN Newswire

牧原股份招股：基石力挺 全球生猪产业龙头企业稀缺价值十足

香港, 2026年1月30日 - (亚太商讯 via SeaPRwire.com) - 在港股市场，投资者可以找到能源、金融、科技、医药领域的行业龙头，却长期缺乏一个能够代表中国现代化农牧业的核心目标。随着牧原食品股份有限公司（「牧原股份」）于1月29日启动港股招股，这一结构性空白有望填补。本次IPO，牧原股份计划全球发售约2.74亿股H股，每手100股，最高发售价39港元，入场费为3939.34港元，预计于2月6日登陆联交所，完成「A+H」双资本平台布局。值得注意的是，牧原股份港股IPO还引入Charoen Pokphand Foods、丰益(Wii Pte. Ltd.及HPRY)、中化香港、香港豫农国际、富达基金、加皇环球资产管理(亚洲)有限公司、Perseverance Asset Management、上海高毅及华泰资本投资(与高毅场外掉期有关)、平安人寿保险、大家人寿、UBS AM Singapore、美的发展控股BVI、Millennium、Jane Street等14家国内外知名机构作为基石投资者，合计认购约6.85亿美元的发售股份，相当于提前锁定约50%的发售股份。这不仅是资本市场对牧原投资价值的重磅背书，也标志着这家全球生猪养殖龙头加速国际化的步伐赢得了全球长期资本的认可。从「规模第一」到「全能冠军」：全产业链铸就不可撼动「护城河」作为连续四年蝉联全球生猪产能及出栏量双冠的龙头企业，牧原股份构建了覆盖生猪育种、生猪养殖、饲料生产、屠宰肉食生猪全产业链垂直一体化的商业模式，不仅实现了全流程可追溯的食品安全管控，更构建了极致的成本控制体系与协同效应，最终达成在规模、效率、成本与质量上的全面领先，成为生猪养殖行业中的稀缺核心资产。在生猪养殖环节，牧原股份通过自主育种体系、优化饲料配方、智能化养殖以及先进的生物安全防控体系，持续推动其养殖成本优化和效率提升。数据显示，2019年到2024年，牧原股份的年均完全成本（即生猪养殖所产生的每公斤（活重当量）总成本及开支）持续保持中国大型生猪养殖企业中最低，2025年全年完全成本进一步降至每公斤12元，在行业周期中构筑其坚实的盈利韧性。屠宰肉食业务作为产业链的重要延伸，自2019年布局以来，牧原股份通过屠宰环节洞察消费需求，反哺育种与养殖端，形成「养殖-屠宰-消费」的动态死循环。这一垂直整合的产业链不仅提升了产品附加值，更通过全程可追溯体系，持续为消费者提供健康、安全、高质价比的猪肉产品。其卓越质量获权威认可：2023年12月，牧原股份成为河南省首家获香港食环署批准的供港冰鲜猪肉注册企业；2024年11月，香港食环署官员实地考察后，对其全链品控体系给予高度评价。短短5年间，牧原股份就在屠宰业务取得了全球领先地位。按2024年屠宰头数计，牧原股份位居中国第一，全球第五。2021至2024年，公司屠宰业务收入复合年均增长率领跑国内大型生猪屠宰肉食企业。2025年前三季度，屠宰量进一步增至约1916.4万头，产能利用率提升至88.1%，并在第三季度实现单季盈利，进一步增强了公司整体盈利的稳定性。稳健经营夯实发展底气 财务强韧与股东回报并行得益于全产业链的协同赋能，牧原股份在取得领先市场地位的同时，仍然保持高速增长。2014-2024年，公司总收入复合年均增长率达48.7%，在全球按照出栏量计算的排名前十的猪肉上市企业中收入增速位列第一。从收入结构来看，2025年前三季度，屠宰肉食业务收入占比已提升至28.5%，成为对冲养殖周期波动、稳定整体业绩的重要支撑。与此同时，极致的成本效率也赋予牧原股份更为强劲的盈利韧性，使其能在市场低谷期保持相对稳健的盈利，而在景气周期则能充分释放利润弹性。即便在生猪价格波动的市场环境下，牧原股份2014-2024年间净利润复合年均增长率达到72.7%，平均年净利润率达到19.0%，是全球按照出栏量计算的排名前十的猪肉上市企业中，唯一一家于2014年至2024年平均年净利润率超过15.0%的企业。稳健的盈利表现，也为牧原股份持续优化财务结构提供了坚实支撑。公司积极推动降负债、稳杠杆，截至2025年三季度末，公司资产负债率为55.50%，负债总额较年初已下降约98亿元，考虑到其10月完成的50亿元权益分派，已经超额完成了2025年年初制定的降负债总额100亿元的目标，财务结构更趋健康。另一方面，过往长期的资本投资已逐渐转化为强大的现金流创造能力。2022-2024 年，牧原股份累计经营活动现金流入净额已 1.6 倍覆盖累计资本性支出，2024 年经营活动现金流入净额是资本性支出的 3.0 倍，2025 年前三季度这一比例进一步提升至 3.9 倍。随着公司大规模的产能建设进入尾声，未来资本开支逐步下降，未来自由现金流水平将稳步提升，为业务扩张与股东回报积蓄充沛弹药。在扎实财务实力支持下，牧原股份持续高额分红，回报股东。2022 年至截至 2025 年 9 月 30 日止九个月，公司累计宣派股息总额达 166 亿元。此外，公司更明确 2024-2026 年股东回报规划，将每年以现金方式分配的利润由不少于当年实现的可供分配利润的40%，为投资者提供了清晰、稳定且具吸引力的回报路径。在生猪行业从规模扩张向高质量转型的当下，牧原股份凭借其全产业链掌控力、极致的成本优势及卓越的盈利表现，展现出穿越行业周期、实现长期增长的强大韧性。此次赴港上市，意味着其国际化发展迈出重要一步。根据招股书，公司计划将募集资金净额的60%用于挖掘海外机遇，扩大商业版图。伴随港股上市完成，牧原不仅将获得更加畅通的国际资本对接渠道，更有望依托这一平台，加速技术输出、品牌国际化与资源整合，进一步巩固其在全球生猪产业中的领先地位，打开更广阔的长期成长空间。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Business

吉尔莫·德尔·托罗（Guillermo Del Toro）的最佳新怪兽电影将迎来重大升级

Netflix(SeaPRwire) -   去年我对它简直爱不释手。吉尔莫·德尔·托罗（Guillermo del Toro）对玛丽·雪莱（Mary Shelley）哥特式恐怖故事的演绎完全把我迷住了；尽管它对原著的处理方式可能存在争议，但显然这是他的代表作。这是一部融合了他诸多影响元素的精彩之作，也是一幅令人动容的父子画卷。我已经看了四遍，但还是渴望从德尔·托罗的世界中获得更多。幸运的是，这位导演对《科学怪人》（Frankenstein）的创作也还没有结束。尽管《科学怪人》（Frankenstein）在Netflix上线已经有几个月了，但围绕这部电影的热度并未消退。它不仅获得了包括最佳影片在内的九项奥斯卡提名，而且据报道，德尔·托罗很快将推出一个加长版。这位导演在今年的圣丹斯电影节（Sundance Film Festival）上展示了他1992年处女作《克诺诺斯》（Cronos）的4K修复版，在那里，他透露自己正在制作一个更长版本的《科学怪人》（Frankenstein）。德尔·托罗没有透露太多关于他所说的“全缝合”版本的信息，但对于那些想重返他那个奇幻世界的人来说，这肯定是个惊喜。《科学怪人》的加长版正在制作中。| Netflix德尔·托罗一直努力让《科学怪人》（Frankenstein）尽可能广泛地上映，为粉丝们提供多样化的观影体验。这部电影在Netflix首播之前就在影院上映了——包括 ，而且德尔·托罗也明确表示它会有实体版发行。对于任何Netflix原创作品来说，这都是一项罕见的成就。虽然这家流媒体平台还没有公布发行日期，但知道它即将推出还是很不错的。德尔·托罗的“全缝合”版本有可能会成为《科学怪人》（Frankenstein）实体版发行的特色之一，但它也有可能让《科学怪人》重新回到影院。它第一次在影院上映的范围相当有限，但在短短几个月内，Netflix与像AMC这样的主流影院连锁的关系已经有所改善。它与AMC合作，对其动画热门影片《韩流驱魔猎人》（KPop Demon Hunters）进行了限时放映。《科学怪人》（Frankenstein）和《火车梦》（Train Dreams）也将作为其 的一部分在AMC影院上映。《科学怪人》的加长版未来也可能会得到同样的待遇，如果是这样，我会去看第五遍。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。《科学怪人》（Frankenstein）正在Netflix上播放。

Latest News

特朗普宣布对古巴进入国家紧急状态，威胁对向共产主义政权供应石油的国家加征关税

(SeaPRwire) -   特朗普总统周四通过行政命令宣布对古巴进入国家紧急状态，指责古巴共产党政权与敌对外国势力和恐怖组织勾结，并着手惩罚向该岛国供应石油的国家。周四的行政命令称，古巴政权的政策和行动构成“对美国国家安全和外交政策的不寻常且非同寻常的威胁，这种威胁全部或主要源自美国境外”。根据该命令，为应对这一威胁，特朗普下令建立关税机制，允许美国对从外国进口的商品征收额外关税，这些外国“直接或间接向古巴出售或以其他方式提供石油”。白宫表示，此举是对古巴政府的重大打击，旨在保护美国的国家安全和外交政策利益。特朗普在命令中称，古巴与“众多对美国怀有敌意的国家、跨国恐怖组织和恶意行为体”结盟并提供支持，提到了俄罗斯、中国、伊朗、哈马斯和真主党。美国政府称，古巴设有俄罗斯最大的海外信号情报设施，该命令称该设施试图窃取美国敏感国家安全信息。命令还称古巴继续深化与中国的情报和国防合作。命令称，古巴“欢迎真主党和哈马斯等跨国恐怖组织”。特朗普还提到古巴政府的人权记录，指责该政权迫害和折磨政治反对派，剥夺言论和新闻自由，并报复和平抗议的政治犯家属。特朗普在命令中表示：“美国对古巴共产党政权的暴行零容忍”，并补充说政府将采取行动追究该政权的责任，同时支持古巴人民对自由民主社会的向往。根据该命令，商务部将确定外国是否直接或通过中介向古巴供应石油。国务院将与财政部、商务部和美国贸易代表办公室合作，决定如果存在这种情况，新关税的幅度及实施方式。国务卿被 tasked 监测国家紧急状态并向国会报告，而商务部将继续追踪哪些国家向古巴供应石油。白宫在一份声明中表示，该命令旨在保护美国国家安全和外交政策免受古巴政权的“恶意行动和政策”侵害，并将此举描述为特朗普更广泛努力的一部分，以应对威胁美国利益的政权。美国政府称，该行动是对特朗普第一任期古巴政策的延续，该政策扭转了奥巴马时代的接触政策，恢复了对古巴共产党政府更严厉的措施。行政命令将于周五生效。白宫未立即回应 Digital 的额外评论请求。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。